Effect of rheumatoid arthritis on volumetric bone mineral density and bone geometry, assessed by peripheral quantitative computed tomography in postmenopausal women treated with bisphosphonates

Journal of Rheumatology

Volumn 39, Issue 6, 2012, Pages 1215-1220

  Tournis, Symeon ^a   Samdanis, Vasilios ^a   Psarelis, Savas ^a,b   Liakou, Chrysa ^a   Antoniou, Julia ^a   Georgoulas, Thomas ^a   Dontas, Ismini ^a   Papaioannou, Nikolaos ^a   Gazi, Susan ^b   Lyritis, George P ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

Bone geometry; Peripheral quantitative computed tomography; Postmenopausal women; Rheumatoid arthritis; Volumetric bone mineral density

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; VITAMIN D;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOMECHANICS; BODY MASS; BONE GEOMETRY; BONE MINERAL; BONE STRESS; CANCELLOUS BONE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PERIOSTEUM; PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THICKNESS; TIBIA; TRABECULAR BONE; VOLUMETRIC BONE MINERAL DENSITY;

AGED; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; POSTMENOPAUSE; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861822367     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110579     Document Type: Article

References (51)

1. Roux C. Osteoporosis in inflammatory joint disease. Osteoporos Int 2011;22:421-33.
2. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19.
3. Silman AJ, Pearson JE. Supplement review: Epidemiology and genetics of rheumatoid arthritis. Arthritis Res Ther 2002;4:S265-72.
4. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
5. Alenfeld FE, Diessel E, Brezger M, Sieper J, Felsenberg D, Braun J. Detailed analyses of periarticular osteoporosis in rheumatoid arthritis. Osteoporosis Int 2000;11:400-7. (Pubitemid 30450122)
6. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000;43:522-30. (Pubitemid 30394942)
7. Sivas F, Barca N, Onder M, Ozoran K. The relation between joint erosion and generalized osteoporosis and disease activity in patients with rheumatoid arthritis. Rheumatol Int 2006;26:896-9. (Pubitemid 43962118)
8. Celiker R, Gokce-Kutsal Y, Cindas A, Ariyurek M, Renda N, Koray Z, et al. Osteoporosis in rheumatoid arthritis: Effect of disease activity. Clin Rheumatol 1995;14:429-33.
9. Pereira RM, Carvalho JF, Canalis E. Glucocorticoid-induced osteoporosis in rheumatic diseases. Clinics Sao Paulo 2010;65:1197-205.
10. van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:3104-12. (Pubitemid 44622079)
11. Orstavik RA, Haugeberg G, Mowinckel P, Hoiseth A, Uhlig T, Falch JA, et al. Vertebral deformities in rheumatoid arthritis. Arch Intern Med 2004;164:420-5.
12. Broy SB, Tanner SB, FRAX® Position Development Conference Members. Official Positions for FRAX® clinical regarding rheumatoid arthritis from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX® . J Clin Densitom 2011;14:184-9.
13. Guler-Yuksel M, Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Groenendael JH, Mallée C, et al. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis 2009;68:330-6.
14. Hoff M, Haugeberg G, Kvien TK. Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss. Arthritis Res Ther 2007;9:R81.
15. Lodder MC, Haugeberg G, Lems WF, Uhlig T, Orstavik RE, Kostense PJ, et al. Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: The Oslo-Truro-Amsterdam OSTRA collaborative study. Arthritis Rheum 2003;49:209-15. (Pubitemid 36418279)
16. Grampp S, Lang P, Jergas M, Glüer CC, Mathur A, Engelke K, et al. Assessment of the skeletal status by peripheral quantitative computed tomography of the forearm: Short-term precision in vivo and comparison to dual X-ray absorptiometry. J Bone Miner Res 1995;10:1566-76.
17. Charopoulos I, Tournis S, Trovas G, Raptou P, Kaldrymides P, Skarandavos G, et al. Effect of primary hyperparathyroidism on volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in postmenopausal women. J Clin Endocrinol Metab 2006;91:1748-53.
18. Schneider P, Börner W. Periphere quantitative Computertomographie zur Knochenmineralmessung mit einem neuen speziellen QCT-Scanner: Methodik, Normbereiche, Vergleich mit manifesten Osteoporosen [Peripheral quantitative computed tomography for bone mineral measurement using a new special QCT-scanner. Methodology, normal values, comparison with manifest osteoporosis]. Rofo 1991;154:292-9.
19. Capozza RF, Feldman S, Mortarino P, Reina PS, Schiessl H, Rittweger J, et al. Structural analysis of the human tibia by tomographic (pQCT) serial scans. J Anat 2010;216:470-81.
20. Szulc P, Seeman E, Duboeuf F, Sornay-Rendu E, Delma P. Bone fragility: Failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. J Bone Miner Res 2006;21:1856-63. (Pubitemid 44851561)
21. Sheu Y, Zmuda JM, Boudreau RM, Petit MA, Ensrud KE, Bauer DC, et al, for the Osteoporotic Fractures in Men (MrOS) Research Group. Bone strength measured by peripheral quantitative computed tomography and the risk of nonvertebral fractures: The Osteoporotic Fractures in Men (MrOS) Study. J Bone Miner Res 2011;26:63-71.
22. Roth J, Palm C, Scheunemann I, Ranke MB, Schweizer R, Guenther E, et al. Musculoskeletal abnormalities of the forearm in patients with juvenile idiopathic arthritis relate mainly to bone geometry. Arthritis Rheum 2004;50:1277-85. (Pubitemid 38480839)
23. Bechtold S, Ripperger P, Dalla Pozza R, Schmidt H, Hafner R, Schwarz HP. Musculoskeletal and functional muscle-bone analysis in children with rheumatic disease using peripheral quantitative computed tomography. Osteoporos Int 2005;16:757-63. (Pubitemid 40933592)
24. Roth J, Linge M, Tzaribachev N, Schweizer R, Kuemmerle-Deschner J. Musculoskeletal abnormalities in juvenile idiopathic arthritis - A 4-year longitudinal study. Rheumatology 2007;46:1180-4. (Pubitemid 47050626)
25. Shibuya K, Hagino H, Morio Y, Teshima R. Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. Clin Rheumatol 2002;21:150-8. (Pubitemid 34649598)
26. Burnham JM, Shults J, Dubner SE, Sembhi H, Zemel BS, Leonard MB. Bone density structure, and strength in juvenile idiopathic arthritis: Importance of disease severity and muscle deficits. Arthritis Rheum 2008;58:2518-27.
27. Felin EM, Prahalad S, Askew EW, Moyer-Mileur LJ. Musculoskeletal abnormalities of the tibia in juvenile rheumatoid arthritis. Arthritis Rheum 2007;56:984-94. (Pubitemid 46399447)
28. Aeberli D, Eser P, Bonel H, Widmer J, Caliezi G, Varisco P, et al. Reduced trabecular bone mineral density and cortical thickness accompanied by increased outer bone circumference in metacarpal bone of rheumatoid arthritis patients: A cross-sectional study. Arthritis Res Ther 2010;12:R119.
29. Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 2010;62:1515-26.
30. Rittweger J, Beller G, Ehrig J, Jung C, Koch U, Ramolla J, et al. Bone-muscle strength indices for the human lower leg. Bone 2000;27:319-26. (Pubitemid 30458829)
31. Stratec Medizintechnik XCT 3000 manual, software version 5.40. Pforzheim, Germany: Stratec Medizintechnik.
32. Haugeberg G, Orstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population. Osteoporosis Int 2003;14:312-9. (Pubitemid 40824247)
33. Iwamoto J, Takeda T, Ichimura S. Forearm bone mineral density in postmenopausal women with rheumatoid arthritis. Calcif Tissue Int 2002;70:1-8. (Pubitemid 36934730)
34. Martin JC, Munro R, Campbell MK, Reid DM. Effect of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis. Comparison with axial measurements. Br J Rheumatol 1997;36:43-9.
35. Enokida M, Yamasaki D, Okano T, Hagino H, Morio Y, Teshima R. Bone mass changes of tibial and vertebral bones in young and adult rats with collagen-induced arthritis. Bone 2001;28:87-93. (Pubitemid 32112066)
36. de Nijs RN, Jacobs JW, Bijlsma JW, Lems WF, Laan RF, Houben HH, et al Osteoporosis Working Group, Dutch Society for Rheumatology. Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology 2001;40:1375-83.
37. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalized bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7. (Pubitemid 24199420)
38. Ibanez M, Ortiz AM, Castrejon I, Garcia-Vadillo J, Carvajal I, Castaneda S, et al. A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass. Arthritis Res Ther 2010;12:R50.
39. Desai SP, Solomon DH. The use of glucocorticoids in rheumatoid arthritis - No 'rational' approach yet. Arthritis Res Ther 2010;12:127.
40. Confavreux CB, Chapurlat RD. Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis. Osteoporosis Int 2011;22:1023-36.
41. Allen MR, Burr DB. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don't know. Bone 2010;49:56-65.
42. Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, et al, for the HORIZON Pivotal Fracture Trial. Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: Results of the HORIZON Pivotal Fracture Trial. Osteoporos Int 2010;21:1277-85.
43. Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003;349:1207-15. (Pubitemid 37152030)
44. McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 2005;165:1762-8. (Pubitemid 41138965)
45. Lewiecki EM, Keaveny TM, Kopperdahl DL, Genant HK, Engelke K, Fuerst T, et al. Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 2009;94:171-80.
46. Felsenberg D, Bock O, Borst H, Armbrecht G, Beller G, Degner C, et al. Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass. J Musculoskelet Neuronal Interact 2010; 11:34-45.
47. Wheeler DL, Vander Griend RA, Wrinski TJ, Miller GJ, Keith EE, Graves JE. The short- and long-term effects of methotrexate on the rat skeleton. Bone 1995;16:215-21.
48. Schwartz AM, Leonidas JC. Methotrexate osteopathy. Skeletal Radiol 1984;11:13-6. (Pubitemid 14211865)
49. Cranney AB, McKendry RJ, Wells GA, Ooi DS, Kanigsberg ND, Kraag GR, et al. The effect of low dose methotrexate on bone density. J Rheumatol 2001;28:2395-9. (Pubitemid 33031967)
50. di Munno O, Mazantini M, Sinigaglia L, Bianchi G, Minisola G, Muratore M, et al. Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: Results from a multicenter cross-sectional study. J Rheumatol 2004;31:1305-9. (Pubitemid 38879193)
51. Pfeil A, Lippold J, Eidner T, Lehman G, Oelzner P, Renz DM, et al. Effects of leflunomide and methotrexate in rheumatoid arthritis detected by digital X-ray radiogrammetry and computer-aided joint space analysis. Rheumatol Int 2009;29:287-95.